GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » 3-Year EPS without NRI Growth Rate

GlycoNex (ROCO:4168) 3-Year EPS without NRI Growth Rate : 3.20% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is GlycoNex 3-Year EPS without NRI Growth Rate?

GlycoNex's EPS without NRI for the three months ended in Mar. 2024 was NT$-0.67.

During the past 3 years, the average EPS without NRI Growth Rate was 3.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was -16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of GlycoNex was 46.30% per year. The lowest was -60.00% per year. And the median was -17.40% per year.


Competitive Comparison of GlycoNex's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, GlycoNex's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlycoNex's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlycoNex's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where GlycoNex's 3-Year EPS without NRI Growth Rate falls into.



GlycoNex 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


GlycoNex  (ROCO:4168) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


GlycoNex 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of GlycoNex's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


GlycoNex (ROCO:4168) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies which targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability and can serve as reagent with applications that include ELISA, Western blot, flow cytometry, TLC immunostaining, and IHC. The group also provides antibody research service to its academic and industrial clients. The other services provided by the firm include functional evaluation, antibody engineering, and antibody characterization.

GlycoNex (ROCO:4168) Headlines

No Headlines